TATVAstockTatva Chintan Pharma Chem Ltd
₹1,193.85
▲+0.69%
Open
₹1,187.85
High
₹1,219
Low
₹1,185.65
Volume
55.5K
Price chart
Daily close · downsampled 5-year history
2021-07-29 · ₹2,310.252026-06-18 · ₹1,204.05
Instrument details
- MB Code
- MBEQU4868
- Type
- stock
- ISIN
- INE0GK401011
- BSE
- 543321
- Industry
- Chemicals & Petrochemicals
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 134.14 Cr
- Net profit
- 10.32 Cr
- EPS
- 4.41
- YoY revenue
- +24.36%
Price returns
Historical performance
- 1 day
- +1.06%
- 1 month
- -6.22%
- 3 months
- +6.79%
- 1 year
- +28.58%
- 3 years
- -32.10%
- 5 years
- -47.88%
Technicals
Indicator consensus
Bullish
23
Neutral
6
Bearish
17
RSI 57.73(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
40Investor presentations
36Corporate announcements
222Corporate timeline
Price chart events · 1 year
Dividend
2025-09-12
{"amount":1}
Earnings
2025-07-24
{"actualRevenue":1168640000,"estimateRevenue":1250000000,"revenueSurprise":-81360000,"revenueSurprisePercent":-6.508799999999999,"actualEPS":2.84,"estimateEPS":2.06,"surprise":0.7799999999999998,"surprisePercent":37.8640776699029}
Earnings
2026-05-16
{"actualRevenue":1341440000,"estimateRevenue":1351000000,"revenueSurprise":-9560000,"revenueSurprisePercent":-0.7076239822353811,"actualEPS":4.41,"estimateEPS":6.592000000000001,"surprise":-2.182,"surprisePercent":-33.10072815533981}
News
2026-04-18
{"description":"Tatva Chintan Pharma Chem's consolidated net profit jumped 901.94% in the March 2026 quarter, with full-year profit up 636.43% to Rs 42.05 crore and sales rising 32.18% to Rs 505.86 crore.","url":"https://www.business-standard.com/markets/capital-market-news/tatva-chintan-pharma-chem-consolidated-net-profit-rises-901-94-in-the-march-2026-quarter-126051800106_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-12-21
{"description":"Tatva Chintan Pharma Chem reported a staggering net profit increase of 10735.71%, reaching Rs 15.17 crore for the quarter ending December 2025, compared to just Rs 0.14 crore in the same quarter last year, indicating strong financial growth.","url":"https://www.business-standard.com/markets/capital-market-news/tatva-chintan-pharma-chem-consolidated-net-profit-rises-10735-71-in-the-december-2025-quarter-126012100979_1.html","sentiment":"Positive","domain":"Business Standard"}